GL1X · GenesisL1 explorer

Research workbench

Mertk kinase domain in complex with a bisaminopyrimidine inhibitor

Analyse Mertk kinase domain in complex with a bisaminopyrimidine inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7AVZ
Type
protein
Length
268 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase mer
EC
2.7.10.1
UniProt
Q12866
Ligands
S4N
Pockets
1 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase mer (EC 2.7.10.1)protein26844% helix, 19% strandQ12866

Ligands and binding sites

  • S4N · (R)-N2-(4-(cyclopropylmethoxy)-3,5-difluorophenyl)-5-(3-methylpiperazin-1-yl)-N4-(tetrahydro-2H-pyran-4-yl)pyrimidine-2,4-diamine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13010.630.8033S4N

Compared structures

  • 7AVZ · MerTK kinase domain in complex with a bisaminopyrimidine inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • Q12866 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase mer (Q12866) · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.